Skip to main content

Jill Fisher, Ph.D. quoted in the BMJ Investigation and interviewed for CBS 17 News.

November 4, 2021
In Paul Thacker’s article for BMJ Investigation “Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial,” he outlined poor practices uncovered by a whistleblower at a research company that was contracted to conduct Pfizer’s covid-19 vaccine trial. In the article, questions were raised about the data’s integrity and...

Partnering Through It: Building a Research Base for Dual-Career Academics

August 30, 2021
Jill Fisher has recently been awarded a 3-year grant from the National Science Foundation that is focused on university hiring practices for and job market experiences of dual-career academics. With long-time research collaborator Prof. Torin Monahan, this Co-PI project will provide a comprehensive analysis of universities’ dual-career policies and practices...

Phase I Trial Compensation: How Much Do Healthy Volunteers Actually Earn from Clinical Trial Enrollment?

August 26, 2021
Background/aims Financial compensation for research participation is a major focus of ethical concern regarding human subject recruitment. Phase I trials are sometimes considered to be a lucrative source of income for healthy volunteers, encouraging some people to become “professional guinea pigs.” Yet, little is known about how much these clinical...

Biomedical Researchers’ Perceptions of the NIH’s Sex as a Biological Variable Policy for Animal Research: Results from a U.S. National Survey

August 26, 2021
Background: In 2015, the National Institutes of Health (NIH) established a policy on sex as a biological variable (SABV) in an effort to address the overrepresentation of men and male animals in biomedical research and the lack of attention to sex-based responses to medical treatments. However, questions remain regarding how...

Ethical Dimensions of Peanut Allergy Immunotherapy Research

August 19, 2021
With funding from the National Institute of Allergy & Infectious Diseases (NIAID), Dr. Jill Fisher is conducting a research study on pediatric clinical trials for food allergies, focusing primarily on peanut allergy. Using ethnographic research methods, the project investigates the on-the-ground ethical challenges that emerge in these clinical trials. In...

Jill Fisher’s Book Wins the Robert K. Merton Book Award

August 12, 2021
Professor Jill A. Fisher’s book, Adverse Events Race, Inequality, and the Testing of New Pharmaceuticals has been awarded the prestigious Robert K. Merton Book Award. The award, given by the Science, Knowledge, and Technology Section of the American Sociological Association. The Merton Award is given annually in recognition of an...

Speculating on Precarious Income: Finance Cultures and the Risky Strategies of Healthy Volunteers in Clinical Drug Trials

January 15, 2021
Speculation has become a normalized occupational strategy and quotidian economic rationality that extends throughout society. Although there are many contemporary articulations of speculation, this article focuses on contract labor as a domain of financialization. Seen through this lens, contract labor can be understood as a speculative investment strategy wherein individuals...

Evaluating the National Institutes of Health’s Sex as a Biological Variable Policy: Conflicting Accounts from the Front Lines of Animal Research

December 1, 2020
Background: Since the National Institutes of Health (NIH) Revitalization Act of 1993, focus on the equitable inclusion of women in clinical research has been ongoing. NIH’s 2015 sex as a biological variable (SABV) policy aims to transform research design, analysis, and reporting in the preclinical sphere by including male and...

Healthy Volunteers

November 1, 2020
This chapter describes the involvement of healthy volunteers in biomedical research. Healthy individuals are valuable to research because they can offer data about biological processes or investigational products that are not distorted by illness or disease. In addition, healthy individuals are generally much easier to recruit to research than are...

Gendered Logics of Biomedical Research: Women in U.S. Phase I Clinical Trials

October 11, 2020
Despite the importance of including diverse populations in biomedical research, women remain underrepresented as healthy volunteers in the testing of investigational drugs in Phase I trials. Contributing significantly to this are restrictions that pharmaceutical companies place on the participation of women of so-called childbearing potential. These restrictions have far-reaching effects...